Tech Company Financing Transactions
Cagent Vascular Funding Round
Cagent Vascular, based in Wayne, secured $11.9 million from Balestier Investments, Ben Franklin Technology Partners and Synergy Partners.
Transaction Overview
Company Name
Announced On
7/13/2018
Transaction Type
Venture Equity
Amount
$11,870,000
Round
Series B
Proceeds Purpose
Proceeds will be used to scale manufacturing and initiate a limited launch of Cagent Vascular's first product, the Serranator Alto.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
150 Strafford Ave. 315
Wayne, PA 19087
USA
Wayne, PA 19087
USA
Phone
Website
Email Address
Overview
Cagent Vascular is leading the way for next generation technology for vessel dilatation. It is the second cardiovascular company formed by co-founders Carol Burns, President & CEO, Peter Schneider, MD, Vascular Surgeon, Chief Medical Officer and Robert Giasolli, VP of Research and Development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carol Burns
Chief Medical Officer
Peter Schneider
Chief Operating Officer
Peter Johansson
Chief Technical Officer
Robert Giasolli
VP - Finance
Aaron Green
Browse more venture capital transactions:
Prev: 7/13/2018: Pointy venture capital transaction
Next: 7/13/2018: Eventbase venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs